Dr. Kaweh Mansouri discusses the results of his study using the EYEMATE-SC sensor to monitor IOP measurements in glaucoma patients, as published in “EYEMATE-SC Trial: Twelve-Month Safety, Performance, and Accuracy of a Suprachoroidal Sensor for Telemetric Measurement of Intraocular Pressure.”

In this presentation from Glaucoma Subspecialty Day 2022, Dr. Andrew Lee explains the Goldilocks principle and when to scan patients with glaucoma.

In this presentation from Glaucoma Subspecialty Day 2022, Dr. Lama Al-Aswad discusses the high prevalence of health disparities in ophthalmology.

In this presentation from Glaucoma Subspecialty Day 2022, Dr. Khizer Khaderi reviews new ways of using visual field testing, optical coherence tomography (OCT), and other traditional diagnostics to identify glaucomatous versus nonglaucomatous disease.

In this presentation from Glaucoma Subspecialty Day 2022, Dr. Amanda Henderson provides an update on optic neuritis in patients with multiple sclerosis (MS) and other demyelinating diseases.

Dr. Lori Provencher discusses telehealth and home monitoring of glaucoma with Dr. Lama A. Al-Aswad, author of “Home Monitoring of Glaucoma Using a Home Tonometer and a Novel Virtual Reality Visual Field Device.”

In this presentation from Glaucoma Subspecialty Day 2022, Dr. Donald Budenz discusses the use of optical coherence tomography (OCT) in diagnosing glaucoma progression. Topics include test reproducibility, the floor effect, and TSNIT—temporal, superior, nasal, inferior, temporal—plots.

In this presentation from Glaucoma Subspecialty Day 2022, Dr. Pradeep Ramulu considers new developments in Humphrey visual field testing. Topics include the speed of newer algorithms, which test pattern to use, and when and how often to perform visual field tests.

Though most people with glaucoma manage well with an eye drop or two and retain their functional vision, a subgroup of glaucoma patients worsen catastrophically over time. Is it possible to identify which group your glaucoma patients will be in? And when should the comprehensive ophthalmologist consider escalation or referral to a glaucoma specialist?